Medication info
Pidogrel Tablets (Clopidogrel Hydrogen Sulfate)

Pidogrel Tablets (Clopidogrel Hydrogen Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
HUBIS Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201404299 · Approved 2014.09.22 · Insurance code 628800240

Summary

Main use
Improvement of symptoms of atherosclerosis; prevention of atherothrombotic and thromboembolic events in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the first day with a loading dose of 300 mg once daily, then administer a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer this medicine 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Experience with treatment in patients with renal impairment is limited. ○ Patients with hepatic impairment: Experience with treatment in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Ingredients

Manufacturer
HUBIS Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of atherosclerosis; prevention of atherothrombotic and thromboembolic events in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral artery disease
  • acute coronary syndrome
  • unstable angina
  • non-ST elevation myocardial infarction
  • cardiovascular events
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atherosclerotic thrombosis
  • thromboembolism
View approved original text

This medication is used to improve atherosclerotic symptoms in adults with ischemic stroke, myocardial infarction, and peripheral artery disease. Additionally, it reduces the risk of death or stroke, myocardial infarction, and other cardiovascular events in patients with acute coronary syndrome, particularly those with unstable angina or non-ST elevation myocardial infarction who have undergone drug therapy, coronary intervention, or coronary artery bypass surgery. Furthermore, it is effective in reducing the risk of stroke and thromboembolism in patients with atrial fibrillation who have one or more vascular risk factors and where vitamin K antagonist therapy is not appropriate. Therefore, this medication is widely used for the prevention and treatment of cardiovascular diseases.

How to take

Adult dose

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the first day with a loading dose of 300 mg once daily, then administer a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer this medicine 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Experience with treatment in patients with renal impairment is limited. ○ Patients with hepatic impairment: Experience with treatment in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Precautions

This medication helps prevent platelets from aggregating, allowing blood to flow properly. Individuals with genetically reduced function of a specific enzyme (CYP2C19) may experience decreased effectiveness of this medication, so alternative treatment options should be considered in such cases. If medications that activate specific enzymes are taken together with this drug, the concentration of this drug may increase, raising the risk of bleeding, so it is advisable to avoid co-administration. Patients who are allergic to this drug or its components, have active bleeding, have severely impaired liver function, are nursing, or have lactose intolerance should not take this medication. Patients at high risk for bleeding or those scheduled for surgery should consult their doctor before taking this drug and may need to stop taking it 5-7 days prior to surgery. This medication inhibits blood coagulation and may cause bleeding; if bleeding symptoms occur, notify a doctor immediately. Caution should be exercised when taking this drug with other medications that increase bleeding risk (e.g., aspirin, warfarin, non-steroidal anti-inflammatory drugs, selective serotonin reuptake inhibitors, etc.). During treatment with this drug, symptoms such as gastrointestinal bleeding, rash, headache, dizziness, diarrhea, nausea, abdominal pain, fatigue, rash, pruritus, ecchymosis/bruising, epistaxis, hematoma, hematuria, urinary tract infection, upper respiratory infection, cough, rhinitis, bronchitis, depression, insomnia, anxiety, myalgia, arthralgia, low back pain, weight gain, weight loss, facial flushing, loss of appetite, vomiting, hiccups, dry mouth, dysphagia, forgetfulness, and abnormal thoughts may occur; consult a doctor if any of these abnormal symptoms arise. The risk to the fetus during pregnancy is unclear; however, do not discontinue treatment in emergency situations such as myocardial infarction or stroke. Nursing mothers should consider discontinuing breastfeeding or the medication as this drug may be excreted in breast milk. Elderly patients or those with impaired renal or liver function have a higher risk of bleeding and require dose adjustments and careful monitoring. In cases of overdose, the risk of bleeding may increase, and as there is no specific antidote, platelet transfusion may be required to prevent bleeding. This medication should be stored out of reach of children for their safety and it is advisable not to transfer it to other containers.

Side effects

Hemorrhage, gastrointestinal bleeding, bleeding requiring hospitalization, purpura, contusion, hematoma, epistaxis, hematuria, intraocular hemorrhage, intracranial bleeding, major hemorrhage, minor hemorrhage, severe hemorrhage, fatal hemorrhage, hemorrhagic stroke, thrombocytopenia, neutropenia, agranulocytosis, aplastic anemia, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, syncope, palpitations, weakness, fever, hernia, heart failure, atrial fibrillation, leg cramps, sensory loss, neuralgia, sensory dysesthesia, vertigo, constipation, vomiting, elevated liver enzymes, gout, hyperuricemia, non-protein nitrogen elevation, arthritis, arthrosis, anxiety, insomnia, anemia, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, gynecomastia, fever, abnormal liver function tests, increased blood creatinine, cholecystitis, hemoptysis, spinal hematoma, allergic symptoms, ischemic necrosis, hemorrhagic arthropathy, hypochromic anemia, leukemia, leukopenia, eosinophilia, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, petechial rash, urticaria, bullous dermatitis, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms, lichen planus, myalgia, glomerulonephritis, gynecomastia, elevated prostate-specific antigen, decreased motor function, tremor, voice disorders, abnormal gait, hyperkinesis, ataxia, perceptual disturbances, insomnia, depression, forgetfulness, dysphoria, abnormal behavior, rigidity, visual disturbances, dry eye syndrome, transient blindness, congestion, tinnitus, urination disorders, pollakiuria, increased non-protein nitrogen, uremia, hypoglycemia, elevated ALT, leg edema, arrhythmia, bradycardia, palpitations, contact dermatitis, elevated prostate-specific antigen

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. Additionally, it is best to store it at room temperature, which should ideally be between 1 and 30 degrees Celsius, avoiding extreme heat or cold.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.